Table of Contents Table of Contents
Previous Page  122 / 464 Next Page
Information
Show Menu
Previous Page 122 / 464 Next Page
Page Background

SUNDAY 7 MAY 2017

122

SCIENTIFIC PROGRAMME

| Programme and Exhibition Guide

Y. Tsang, R. Huddart

OC-0351

16:40 > CBCT-guided evolutive library for cervix adaptive IMRT

B. Rigaud (France), A. Simon, M. Gobeli, C. Lafond, D. Williaume,

J. Leseur, J. Castelli, P. Haigron, R. De Crevoisier

OC-0352

16:50 > Implementation of RTT led ‘plan of the day’ adaptive radiotherapy in

cervical cancer

A. Baker (UK), T. Hague, Y. Tsang, P.J. Hoskin

OC-0353

17:00 > Dosimetric impact of anatomical changes in photon and particle

therapy for pancreatic cancer

K. Crama (The Netherlands), A.C. Houweling, J. Visser, K. Fukata,

C.R.N. Rasch, T. Ohno, A. Bel, A. Van der Horst

OC-0354

17:10 > Which anatomical changes in Head and Neck cancer lead to Repeat

CT/planning?

S. Van Beek, O. Hamming-Vrieze, A. Al Mamgani,

A. Navran, J. Van de Kamer (The Netherlands), P. Remeijer

OC-0355

17:20 > Adaptive strategy for rectal cancer: evaluation of plan selection of the

first 20 clinical patients

R. De Jong (The Netherlands), N. Van Wieringen, J. Visser, J. Wiersma,

K. Crama, D. Geijsen, L. Lutkenhaus, A. Bel

OC-0356

PROFFERED PAPERS

Physics Dosimetry

16:30 - 17:30 | STOLZ 1-2

Chair: L. Beaulieu (Canada)

Chair: J. Hofbauer (Austria)

> Abstract withdrawn

OC-0357

16:30 > Evaluation of the Advanced Collapsed-cone Engine dose calculation

algorithm for COMS eye plaques

H. Morrison (Canada), G. Menon, M. Larocque, E. Weis, R. Sloboda

OC-0358

16:42 > Microdosimetric evaluation of intermediate-energy brachytherapy

sources using Geant4-DNA

G. Famulari (Canada), P. Pater, S.A. Enger

OC-0359

16:54 > Dose warping uncertainties for the cumulative rectal wall dose from

brachytherapy in cervical cancer

L.E. Van Heerden (The Netherlands), N. Van Wieringen, C. Koedooder,

C.R.N. Rasch, B.R. Pieters, A. Bel

OC-0360

17:06 > Commissioning of applicator-guided SBRT with HDR Brachytherapy

for Advanced Cervical Cancer

S. Aldelaijan, S. Wadi-Ramahi (Saudi Arabia), A. Nobah, N. Jastaniyah

OC-0361